637P AC699, a novel chimeric estrogen receptor degrader, in a phase I study in breast cancer von Hamilton, E.P., Layman, R., Danso, M.A., Cosgrove, D., Wang, X., Zhang, H., Brown, G., Kim, S.Y., Patel, M.R.

Volltext

73TiP Global phase III studies evaluating vepdegestrant in estrogen receptor (ER)+/human epidermal growth factor receptor 2 (HER2)- advanced breast cancer: VERITAC-2 and VERITAC-3 von Iwata, H., Hamilton, E.P., Ma, C.X., De Laurentiis, M., Hurvitz, S.A., Wander, S.A., Danso, M.A., Lu, D.R., Perkins, J., Liu, Y., Tran, L., Anderson, S., Chappey, C., Yang, D.Z., Campone, M.

Volltext

257TiP VERITAC-2: A global, randomized phase III study of ARV-471, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, vs fulvestrant in ER+/human epidermal g... von Hamilton, E., Ma, C.X., De Laurentiis, M., Iwata, H., Hurvitz, S.A., Wander, S.A., Danso, M.A., Lu, D.R., Perkins, J., Liu, Y., Tran, L., Anderson, S., Campone, M.

Volltext

201P Trilaciclib combined with sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC): Preliminary phase II results von Seneviratne, L., Harnden, K.K., Mardones, M., Blau, S., Gillespie-Twardy, A., Danso, M.A., Berz, D., Guaqueta, D., Schwerkoske, J., O'Shaughnessy, J., Patt, D., Bardia, A., Beelen, A., Oyekunle, T., Dell, V., Hurvitz, S.A.

Volltext

Nodulation, N2 fixation and yield of chickpea as influenced by host cultivar and Bradyrhizobium strain differences von SATTAR, M. A, QUADER, M. A, DANSO, S. K. A

Volltext

Nodulation, N 2 fixation and yield of chickpea as influenced by host cultivar and Bradyrhizobium strain differences von Sattar, M.A., Quader, M.A., Danso, S.K.A.

Volltext